文献速递物质与行为成瘾精神分裂症与精神病性障碍心境障碍

氯胺酮对多巴胺能功能的影响:荟萃分析与神经精神疾病意义综述

The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.
PubMed 文献 · Mol Psychiatry · 2017-10-03

该系统综述与荟萃分析检索PubMed和PsychInfo,纳入40项原创研究,评估急性和慢性氯胺酮给药后啮齿类、人类和灵长类脑内多巴胺指标变化。急性亚麻醉剂量氯胺酮在啮齿类显著增加皮层、纹状体和伏隔核多巴胺水平及多巴胺神经元群体活动,但灵长类和人类PET研究结果不一致。

要点

  • 急性亚麻醉剂量氯胺酮在啮齿类增加皮层、纹状体和伏隔核多巴胺水平。
  • 急性氯胺酮增加啮齿类多巴胺神经元群体活动62-180%。
  • 灵长类和人类PET研究结果不一致,慢性给药研究不足以荟萃分析。

核心结论

  • 急性氯胺酮给药导致啮齿类脑内多巴胺释放。
  • 氯胺酮诱导的多巴胺释放存在种间差异,对理解物质滥用、精神分裂症和抗抑郁特性有启示。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed和PsychInfo电子数据库,纳入40项原创同行评议研究。
  • 比较急性和慢性氯胺酮给药后啮齿类、人类和灵长类脑内多巴胺指标与无药基线或对照条件。

主要发现

  • 急性亚麻醉剂量氯胺酮在啮齿类显著增加皮层多巴胺水平(Hedge's g=1.33,P<0.01)。
  • 急性亚麻醉剂量氯胺酮在啮齿类显著增加纹状体多巴胺水平(Hedge's g=0.57,P<0.05)。
  • 急性亚麻醉剂量氯胺酮在啮齿类显著增加伏隔核多巴胺水平(Hedge's g=1.30,P<0.05)。
  • 急性氯胺酮增加啮齿类多巴胺神经元群体活动62-180%。
  • 亚组分析显示在体研究升高(g=1.93)比离体研究(g=0.50)更明显。

关键数值与推荐

  • 急性亚麻醉剂量氯胺酮在啮齿类皮层多巴胺升高Hedge's g=1.33(P<0.01)。
  • 急性亚麻醉剂量氯胺酮在啮齿类纹状体多巴胺升高Hedge's g=0.57(P<0.05)。
  • 急性亚麻醉剂量氯胺酮在啮齿类伏隔核多巴胺升高Hedge's g=1.30(P<0.05)。
  • 急性氯胺酮增加啮齿类多巴胺神经元群体活动62-180%。
  • 慢性氯胺酮给药研究报告皮层多巴胺水平持续增加88-180%。

临床怎么用

  • 氯胺酮的急性多巴胺释放效应可为理解其抗抑郁和成瘾潜力提供机制线索。
  • 种间差异提示将啮齿类多巴胺发现外推到人类时需谨慎。

局限性

  • 海马、腹侧苍白球和小脑研究不足以荟萃分析。
  • 慢性氯胺酮给药研究不足以荟萃分析。
  • 非人灵长类和人类PET研究结果不一致。
  • 麻醉剂量(>100 mg kg-1)氯胺酮对离体多巴胺水平无影响,但在体研究尚待测试。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketamine is a non-competitive antagonist at the N-methyl-d-aspartate receptor. It has recently been found to have antidepressant effects and is a drug of abuse, suggesting it may have dopaminergic effects. To examine the effect of ketamine on the dopamine systems, we carried out a systematic review and meta-analysis of dopamine measures in the rodent, human and primate brain following acute and chronic ketamine administration relative to a drug-free baseline or control condition. Systematic search of PubMed and PsychInfo electronic databases yielded 40 original peer-reviewed studies. There were sufficient rodent studies of the acute effects of ketamine at sub-anaesthetic doses for meta-analysis. Acute ketamine administration in rodents is associated with significantly increased dopamine levels in the cortex (Hedge's g= 1.33, P<0.01), striatum (Hedge's g=0.57, P<0.05) and the nucleus accumbens (Hedge's g=1.30, P<0.05) compared to control conditions, and 62-180% increases in dopamine neuron population activity. Sub-analysis indicated elevations were more marked in in vivo (g=1.93) than ex vivo (g=0.50) studies. There were not enough studies for meta-analysis in other brain regions studied (hippocampus, ventral pallidum and cerebellum), or of the effects of chronic ketamine administration, although consistent increases in cortical dopamine levels (from 88 to 180%) were reported in the latter studies. In contrast, no study showed an effect of anaesthetic doses (>100 mg kg-1) of ketamine on dopamine levels ex vivo, although this remains to be tested in vivo. Findings in non-human primates and in human studies using positron emission tomography were not consistent. The studies reviewed here provide evidence that acute ketamine administration leads to dopamine release in the rodent brain. We discuss the inter-species variation in the ketamine induced dopamine release as well as the implications for understanding psychiatric disorders, in particular substance abuse, schizophrenia, and the potential antidepressant properties of ketamine, and comparisons with stimulants and other NMDA antagonists. Finally we identify future research needs.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kokkinou M, Ashok AH, Howes OD, et al. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry. 2017. PMID: 28972576. doi:10.1038/mp.2017.190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。